Ameriprise
LKFT

Ameriprise’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Ameriprise’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38.1M Sell
1,272,249
-152,425
-11% -$4.33M 0.01% 1087
2026
Q1 		$42.7M Sell
1,424,674
-26,565
-2% -$880K 0.01% 955
2025
Q4 		$47.5M Buy
1,451,239
+34,305
+2% +$1.11M 0.01% 910
2025
Q3 		$49.1M Buy
1,416,934
+1,362,229
+2,490% +$43.6M 0.01% 889
2025
Q2 		$1.53M Sell
54,705
-9,995
-15% -$268K ﹤0.01% 3090
2025
Q1 		$1.63M Sell
64,700
-5,713
-8% -$144K ﹤0.01% 3003
2024
Q4 		$1.94M Sell
70,413
-10,412
-13% -$290K ﹤0.01% 2945
2024
Q3 		$2.33M Sell
80,825
-25,199
-24% -$686K ﹤0.01% 2846
2024
Q2 		$2.63M Buy
106,024
+1,806
+2% +$51.2K ﹤0.01% 2739
2024
Q1 		$3.36M Sell
104,218
-2,624
-2% -$97.6K ﹤0.01% 2612
2023
Q4 		$4.34M Buy
106,842
+17,498
+20% +$644K ﹤0.01% 2462
2023
Q3 		$3.09M Buy
89,344
+39,197
+78% +$1.53M ﹤0.01% 2609
2023
Q2 		$2.04M Buy
50,147
+11,840
+31% +$483K ﹤0.01% 2861
2023
Q1 		$1.48M Buy
+38,307
New +$1.57M ﹤0.01% 2979
2020
Q3 		– Sell
-1,913
Closed -$377K – 3749
2020
Q2 		$377K Buy
1,913
+551
+40% +$114K ﹤0.01% 3290
2020
Q1 		$267K Sell
1,362
-26
-2% -$5.59K ﹤0.01% 3348
2019
Q4 		$287K Buy
+1,388
New +$257K ﹤0.01% 3490
2019
Q3 		– Sell
-2,552
Closed -$329K – 3730
2019
Q2 		$329K Buy
2,552
+530
+26% +$62.9K ﹤0.01% 3459
2019
Q1 		$238K Buy
+2,022
New +$204K ﹤0.01% 3505

Other funds holding LKFT

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
DCM
DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Ameriprise's LKFT Position: Q2 2026 in Review

Ameriprise reduced its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 11% in Q2 2026, selling an estimated $4.33M and leaving 1,272,249 shares worth $38.1M. The position accounts for 0.01% of the portfolio, ranked #1087.

Ameriprise first reported a position in LKFT in Q1 2019 and has held it in 19 quarters since. The position peaked at $49.1M in Q3 2025. 76 funds tracked by Wall St. Rank hold LKFT as of Q2 2026.

  • Ameriprise held 1,272,249 shares of Lakefront Biotherapeutics American Depositary Shares worth $38.1M as of Q2 2026.
  • Ameriprise sold 152,425 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2026, an estimated $4.33M.
  • Lakefront Biotherapeutics American Depositary Shares made up 0.01% of Ameriprise's portfolio in Q2 2026, its #1087 holding.
  • Ameriprise first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2019 and has held it in 19 quarters since.
  • Ameriprise's Lakefront Biotherapeutics American Depositary Shares position peaked at $49.1M in Q3 2025.
  • 76 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.